SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-19-006445
Filing Date
2019-03-06
Accepted
2019-03-06 16:31:15
Documents
2
Period of Report
2019-02-28

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 8447
2 EX-24 DOCUMENT attachment1.htm EX-24 3213
  Complete submission text file 0000899243-19-006445.txt   13053
Mailing Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803
Business Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803 617-517-0730
scPharmaceuticals Inc. (Issuer) CIK: 0001604950 (see all company filings)

IRS No.: 465184075 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SCPHARMACEUITCALS, INC. 2400 DISTRICT AVENUE BURLINGTON MA 01803
Business Address
Nokes Rachael (Reporting) CIK: 0001769138 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38293 | Film No.: 19662884